Terms: = Gastric cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
4 results:
1. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment.
Bosch KD; Chicklore S; Cook GJ; Davies AR; Kelly M; Gossage JA; Baker CR
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):759-767. PubMed ID: 31377821
[TBL] [Abstract] [Full Text] [Related]
2. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal cancer: A Propensity Score-Matched Analysis.
Mokdad AA; Yopp AC; Polanco PM; Mansour JC; Reznik SI; Heitjan DF; Choti MA; Minter RR; Wang SC; Porembka MR
JAMA Oncol; 2018 Jan; 4(1):31-38. PubMed ID: 28975352
[TBL] [Abstract] [Full Text] [Related]
4. Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.
Lao-Sirieix P; Boussioutas A; Kadri SR; O'Donovan M; Debiram I; Das M; Harihar L; Fitzgerald RC
Gut; 2009 Nov; 58(11):1451-9. PubMed ID: 19651633
[TBL] [Abstract] [Full Text] [Related]
